Rocket Pharmaceuticals, Inc. (RCKT)
3.41
-0.09
(-2.57%)
USD |
NASDAQ |
Sep 18, 15:07
Rocket Pharmaceuticals 1 Year Total Returns (Daily) : 15.51% for Sept. 17, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 17, 2026 | 15.51% |
| September 16, 2026 | 7.08% |
| September 15, 2026 | 5.90% |
| September 14, 2026 | 8.54% |
| September 11, 2026 | 2.13% |
| September 10, 2026 | 9.43% |
| September 09, 2026 | 13.08% |
| September 08, 2026 | 13.80% |
| September 04, 2026 | 19.50% |
| September 03, 2026 | 14.16% |
| September 02, 2026 | 19.14% |
| September 01, 2026 | 13.72% |
| August 31, 2026 | 13.41% |
| August 28, 2026 | 15.22% |
| August 27, 2026 | 9.04% |
| August 26, 2026 | 7.96% |
| August 25, 2026 | 6.78% |
| August 24, 2026 | -3.02% |
| August 21, 2026 | -5.90% |
| August 20, 2026 | -7.20% |
| August 19, 2026 | 25.43% |
| August 18, 2026 | 10.23% |
| August 17, 2026 | 11.48% |
| August 14, 2026 | 14.52% |
| August 13, 2026 | 8.09% |
| Date | Value |
|---|---|
| August 12, 2026 | 17.18% |
| August 11, 2026 | 19.86% |
| August 10, 2026 | 27.27% |
| August 07, 2026 | 16.83% |
| August 06, 2026 | 17.22% |
| August 05, 2026 | 15.13% |
| August 04, 2026 | 12.05% |
| August 03, 2026 | 14.05% |
| July 31, 2026 | 1.97% |
| July 30, 2026 | 2.23% |
| July 29, 2026 | 4.32% |
| July 28, 2026 | 0.96% |
| July 27, 2026 | 3.50% |
| July 24, 2026 | -0.62% |
| July 23, 2026 | -2.38% |
| July 22, 2026 | -2.08% |
| July 21, 2026 | 8.63% |
| July 20, 2026 | 12.83% |
| July 17, 2026 | 2.99% |
| July 16, 2026 | 19.23% |
| July 15, 2026 | 29.89% |
| July 14, 2026 | 19.34% |
| July 13, 2026 | 25.68% |
| July 10, 2026 | 23.73% |
| July 09, 2026 | 30.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 132.5% |
| Oncolytics Biotech, Inc. | -42.96% |
| Sangamo Therapeutics, Inc. | -72.48% |
| Sarepta Therapeutics, Inc. | 21.23% |
| Anixa Biosciences, Inc. | -17.61% |